Iowa Medicaid Drug Utilization Review Commission
New Public Comment Policy
Data that is to be referenced during the Public Comment period(s) should be limited to published, peer reviewed literature only. “Data on file” and “articles submitted for review” are not considered published, peer reviewed literature and should not be referenced during public testimony.
All referenced data that is to be presented should be submitted to the DUR professional staff electronically to email@example.com AT LEAST ONE WEEK PRIOR TO THE MEETING DATE for consideration and distribution to the Commission members. The deadline is 4:30 p.m. CT Wednesday, before the scheduled meeting date. Anything submitted to the DUR professional staff after this deadline will be distributed to the Commission members for the next scheduled DUR meeting.
DUR Commission Members
- Mark Graber, M.D., FACEP, Chairperson
- Laurie Pestel, Pharm.D., Vice Chairperson
- Larry Ambroson, R.Ph.
- Gregory Barclay, M.D.
- Brian Couse, M.D.
- Brett Faine, Pharm.D.
- Kellen Ludvigson, Pharm.D.
- Susan Parker, Pharm.D.
- Jason Wilbur, M.D.
- Pam Smith, R.Ph. - DUR Project Coordinator